Approved for the treatment of vaginal laxity.

ThermiVa benefits:

  • Non-surgical, non-invasive treatment,
  • Radiofrequency generated treatment through heat,
  • No anesthesia required. In a clinical study, patients reported little to no discomfort during treatments,
  • Little to no down time,
  • Clinical data shows that more than 93% of women treated had improvements of vaginal laxity.
ThermiVa treatment:

  • Convenient treatment performed in-office,
  • Treatment protocol includes three treatments, approximately one month apart, with visible tissue change and continued improvement with each treatment,
  • Each treatment takes approximately 30-40 minutes (actual treatment  time),
  • Maintenance may be needed at approximately one year to maintain best results.
55 000 ThermiVa applications performed worldwide.

ThermiVa is certified, licensed and approved internationally by BSI EC for Europe, Health Canada and the FDA in the USA.

BSI EC -Certificate No. CE630665.
Health Canada  - Medical device Licence no. 67329 issued 7/2/2005.
FDA  - Device Certificate of equivalence- K130689 

ThermiVa Animation Video

Warning: This video is not suitable for children

RealSelf Website for ThermiVa feedback